バイオ医薬品CMO・CRO市場：供給源別、サービス別、製品別、地域別 - 市場規模、シェア、展望、機会分析、2023年～2030年

バイオ医薬品CMO（医薬品製造受託機関）とは、バイオ医薬品セクターの他の企業に対し、医薬品製造サービスからパッケージングまでのサービスを受託する企業です。一方、CRO（医薬品開発業務受託機関）とは、研究業務を受託してバイオ医薬品企業を支援する企業です。

市場力学：

慢性疾患の増加、創薬開発の増加、生物製剤やバイオシミラーの需要増加、アウトソーシングの増加傾向、研究開発投資の増加、バイオ医薬品産業の急成長などが、世界のバイオ医薬品CMO・CRO市場の成長を押し上げる主な要因です。

例えば、2023年2月、LunaphoreとSirona Dxは戦略的提携を発表し、Sirona DxはLunaphoreの主力製品であるCOMET空間生物学プラットフォームをサービスとして提供する米国初のCROとなります。COMETは、Sirona Dxの研究サービスポートフォリオを補完し、様々な分野の研究者やバイオファーマチームのニーズに対応します。COMETは、様々な分野、研究・医薬品開発のあらゆる段階において、幅広い研究アプリケーションを提供します。

本調査の主な特徴

• 本レポートでは、世界のバイオ医薬品CMO・CRO市場を詳細に分析し、2022年を基準年とした予測期間（2023～2030年）の市場規模および年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにおける潜在的な収益機会を明らかにし、この市場に対する魅力的な投資提案のマトリックスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 世界のバイオ医薬品CMO・CRO市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要業績、財務実績、戦略などのパラメータに基づいてプロファイルしています。
• 本調査の対象となる主要企業には、AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials（ACT）, Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, Alliance for Clinical Trials in Oncologyなどが含まれます。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。
• 世界のバイオ医薬品CMO・CRO市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界のバイオ医薬品CMO・CRO市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場概況

• レポート概要
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 世界のアウトソーシング動向の高まり
  • 厳しい規制の枠組み
  • バイオ医薬品産業の急成長
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品上市/承認
• PEST分析
• ポーターの分析
• 合併・買収シナリオ

第4章 世界のバイオ医薬品CMO・CRO市場 - コロナウイルス（COVID-19）パンデミックの影響

• COVID-19疫学
• 供給サイドと需要サイドの分析
• 経済的影響

第5章 バイオ医薬品CMO・CROの世界市場：供給源別、2023-2030年

• 哺乳類
• 非哺乳類

第6章 バイオ医薬品CMO・CROの世界市場：サービス別、2023-2030年

• 医薬品製造受託
• 医薬品開発業務受託

第7章 バイオ医薬品CMO・CROの世界市場：製品別、2023-2030年

• バイオ医薬品
• バイオシミラー

第8章 バイオ医薬品CMO・CROの世界市場：地域別、2023-2030年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• Allphase Clinical Research
• AlcheraBio
• Alcami
• Akos Urgent Care
• Agilent
• AGC Biologics
• Affinity Life Sciences, Inc.
• Actimus Bio
• ACI Clinical
• Accumedix, Inc.
• Absorption Systems
• A10 Clinical Solutions
• Albuquerque Clinical Trials（ACT）
• Ajinomoto Bio-Pharma Services
• Advanced Clinical Services LLC
• ACM Global Laboratories
• Accelerated Enrollment Solutions
• AbbVie Contract Manufacturing
• Advanced BioScience Laboratories
• Advanced Clinical Research Institute
• Alliance for Clinical Trials in Oncology

第10章 セクション

• 調査手法
• 出版社について

Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.

Market Dynamics:

Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.

For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.

Key features of the study:

• This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.

Detailed Segmentation:

• Global Biopharmaceutical CMO and CRO Market, By Source:
  • Mammalian
  • Non-mammalian
• Global Biopharmaceutical CMO and CRO Market, By Service:
  • Contract Manufacturing
  • Contract Research
• Global Biopharmaceutical CMO and CRO Market, By Product:
  • Biologics
  • Biosimilars
• Global Biopharmaceutical CMO and CRO Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Allphase Clinical Research
  • AlcheraBio
  • Alcami
  • Akos Urgent Care
  • Agilent
  • AGC Biologics
  • Affinity Life Sciences, Inc.
  • Actimus Bio
  • ACI Clinical
  • Accumedix, Inc.
  • Absorption Systems
  • A10 Clinical Solutions
  • Albuquerque Clinical Trials (ACT)
  • Ajinomoto Bio-Pharma Services
  • Advanced Clinical Services LLC
  • ACM Global Laboratories
  • Accelerated Enrollment Solutions
  • AbbVie Contract Manufacturing
  • Advanced BioScience Laboratories
  • Advanced Clinical Research Institute
  • Alliance for Clinical Trials in Oncology

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Source
  • Market Snapshot, By Service
  • Market Snapshot, By Product
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing trend of outsourcing across the globe
  • Stringent regulatory framework
  • Rapid growth of the biopharmaceutical industry
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Biopharmaceutical CMO and CRO Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Biopharmaceutical CMO and CRO Market, By Source, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Non-mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Biopharmaceutical CMO and CRO Market, By Service, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Contract Manufacturing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Contract Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Biopharmaceutical CMO and CRO Market, By Product, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Biologics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Biosimilars
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Global Biopharmaceutical CMO and CRO Market, By Region, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)

9. Competitive Landscape

• Allphase Clinical Research
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AlcheraBio
• Alcami
• Akos Urgent Care
• Agilent
• AGC Biologics
• Affinity Life Sciences, Inc.
• Actimus Bio
• ACI Clinical
• Accumedix, Inc.
• Absorption Systems
• A10 Clinical Solutions
• Albuquerque Clinical Trials (ACT)
• Ajinomoto Bio-Pharma Services
• Advanced Clinical Services LLC
• ACM Global Laboratories
• Accelerated Enrollment Solutions
• AbbVie Contract Manufacturing
• Advanced BioScience Laboratories
• Advanced Clinical Research Institute
• Alliance for Clinical Trials in Oncology
• Analyst Views

10. Section

• Research Methodology
• About us